N2

Opioid regimen tolerated, bowel maintained

Skilled pain assessment completed. Pain 3/10, at the goal of 3, on the around-the-clock opioid regimen; quality aching; no new breakthrough pain. Function maintained and sleep restful. Sedation at an acceptable level with a respiratory rate of 16; bowel function maintained on the prescribed bowel regimen with a normal recent bowel movement; no nausea. Findings at goal with no untreated adverse effects. RN-level assessment was required to evaluate regimen effectiveness and screen for opioid-related sedation, respiratory depression, and constipation. Opioid safety and bowel prophylaxis reinforced; teach-back accurate. Continued skilled monitoring indicated.

N3

Nonverbal patient, PAINAD at baseline

Skilled pain assessment completed for a nonverbal patient with advanced dementia using the PAINAD observational scale. Score 1/10 observed during repositioning and personal care: calm breathing, no negative vocalization, a relaxed facial expression, relaxed body language, and full consolability. Findings indicate well-controlled pain at baseline. RN-level assessment was required to apply a validated observational scale appropriate to a nonverbal patient and evaluate the scheduled analgesic regimen. The caregiver was coached to recognize the behavioral indicators that signal pain and when to call; teach-back accurate. Continued skilled monitoring indicated.

N4

Post-operative pain improving, function returning

Skilled pain assessment completed at the post-surgical visit. Incisional pain 3/10, down from 6/10 at the prior visit and at the goal of 3; quality aching at the surgical site, worse with movement and relieved by the regimen and positioning; no signs of infection at the site. Ambulation distance and transfers have improved. The tapering analgesic regimen is tolerated without adverse effects. Findings reflect expected recovery. RN-level assessment was required to evaluate the trajectory of post-operative pain, confirm function is returning, and screen for regimen adverse effects. Activity pacing, the taper, and warning signs reinforced; teach-back accurate. Continued skilled monitoring indicated.

N5

Neuropathic pain controlled on adjuvant

Skilled pain assessment completed. The patient reports burning, tingling pain in both feet at 3/10, at the goal of 3, on the adjuvant regimen; pattern constant but reduced from prior visits; no new sites. Sleep and ambulation are at baseline. The adjuvant medication is tolerated without sedation or dizziness. Findings indicate controlled neuropathic pain. RN-level assessment was required to characterize the neuropathic features, evaluate the response to the adjuvant agent, and screen for its adverse effects. Foot protection, adherence, and call criteria reinforced; teach-back accurate. Continued skilled monitoring indicated.

N6

As-needed regimen effective, function preserved

Skilled pain assessment completed. The patient reports intermittent low-back pain reaching 4/10 with activity, at the goal of 4, controlled with the as-needed analgesic and nonpharmacologic measures; quality aching; no radiation or neurologic symptoms. Function, sleep, and mood are at baseline. The as-needed regimen is used within ordered limits and tolerated. Findings at goal. RN-level assessment was required to evaluate the adequacy of the as-needed regimen, screen for escalation or red-flag features, and confirm function is preserved. Body mechanics, pacing, and the dosing limit reinforced; teach-back accurate. Continued skilled monitoring indicated.